Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 27, Number 8—August 2021
Research Letter

Linezolid- and Multidrug-Resistant Enterococci in Raw Commercial Dog Food, Europe, 2019–2020

Ana R. Freitas12, Liliana Finisterra, Ana P. Tedim2, Bárbara Duarte, Carla Novais12, Luísa Peixe12Comments to Author , and from the ESCMID Study Group on Food- and Water-borne Infections (EFWISG)
Author affiliations: Instituto Universitário de Ciências da Saúde (IUCS) Departamento de Ciências, Cooperativa de Ensino Superior Politécnico e Universitário (CESPU), CRL, Gandra, Portugal (A.R. Freitas); UCIBIO, Faculdade de Farmácia, Universidade do Porto, Porto, Portugal (A.R. Freitas, L. Finisterra, B. Duarte, C. Novais, L. Peixe); Hospital Universitario Rio Hortega/Instituto de Investigación Biomédica de Salamanca, Valladolid/Salamanca, Spain (A.P. Tedim)

Main Article

Table

Characterization of Enterococcus isolates obtained from raw dog food samples, Porto, Portugal, 2019–2020*

Species cgMLST† MLST‡ Sample (brand)§ Antimicrobial drug resistance profile# Antibiotic resistance genotype MIC LIN,
mg/L
Transfer
of LinR
genes
E. faecalis CT1206 ST40 Duck (B) ERY, TET, CHL, LIN optrA, fexA, cat, erm(B), Isa(A), tet(M), dfr(G) 8
CT1207 ST674 Salmon (A) CIP, ERY, TET, STR, CHL, LIN optrA, cfrD, fexA, cat, ant(6)-Ia, aph(3′)-III, erm(B), Isa(A), tet(M), tet(L), dfr(G) 8 ++
CT1205 ST1008 Turkey (A)¶ ERY, TET, GEN, STR, CHL optrA, poxtA, fexB, cat, aac(6')-aph(2”), ant(6)-Ia, ant(9)-Ia, aph(3′)-III, erm(B), lnu(B), Isa(A), Isa(E), tet(M), tet(L), dfr(G) 4
CT1205 ST1008 Turkey (A)¶ ERY, TET, STR, CHL optrA, poxtA, fexB, cat, aac(6')-aph(2”), ant(6)-Ia, ant(9)-Ia, aph(3′)-III, erm(B), lnu(B), Isa(A), Isa(E), tet(M), tet(L), dfr(G) 4
CT1209 ST1008 Chicken + lamb (A) ERY, TET, STR, CHL, LIN optrA, poxtA, fexB, cat, aac(6')-aph(2”), ant(6)-Ia, ant(9)-Ia, aph(3′)-III, erm(B), lnu(B), Isa(A), Isa(E), tet(M), tet(L), dfr(G) 8

CT1208
ST1009
Turkey + goose (B)
ERY, CHL, LIN
optrA, cfrD, fexA, cat, erm(B), Isa(A), dfr(G)
8

E. faecium CT106 ST80 Salmon (A) AMP (>256 mg/L), CIP, ERY, TET, GEN, STR, QD aac(6')-aph(2”), ant(6)-Ia, aph(3′)-III, erm(B), msr(C), tet(M), tet(L), dfr(G) ND NA
CT284 ST25 Beef (A) AMP (32 mg/L), CIP, ERY, TET, GEN, STR, QD, CHL poxtA, fexB, aac(6')-aph(2”), ant(6)-Ia, ant(9)-Ia, aph(3′)-III, erm(A), erm(B), msr(C), Inu(B), Isa(E), tet(M), tet(L), dfr(G) 4
CT374 ST264 Beef (A) AMP (32 mg/L), CIP, TET, STR, QD cat, ant(6)-Ia, Inu(G), tet(M), tet(L), dfr(G) ND NA
CT272 ST1091 Duck (B) AMP (>256 mg/L), CIP, ERY, TET, STR, QD ant(9)-Ia, erm(A), erm(B), msr(C), tet(M), tet(L), dfr(G) ND NA
CT3399 ST1263 Deer (B) AMP, ERY, TET, STR, QD, CHL poxtA, fexB, cat, ant(6)-Ia, ant(9)-Ia, aph(3′)-III, erm(A), msr(C), Inu(B), Isa(E), tet(L), dfr(G) 4 +

*AMP, ampicillin; cgMLST, core-genome MLST; CIP, ciprofloxacin; CHL, chloramphenicol; CT, complex type; ERY, erythromycin; GEN, high-level resistance to gentamicin; LIN, linezolid; LinR, linezolid-resistant; MLST, multilocus sequence typing; NA, not applicable; ND, not done: QD, quinupristin/dalfopristin; STR, high-level resistance to streptomycin; ST, sequence type: +, positive (transfer frequency of 10−8); ++, positive (transfer frequency of 10−7); –, negative. †The E. faecalis CT1205-CT1209 and the E. faecium CT3399 were identified in this study by submitting them to the cgMLST database (https://www.cgMLST.org) through Ridom SeqSphere+ version 7.2 software (https://www.ridom.de/seqsphere). ‡The novel E. faecalis ST1008–ST1009 were submitted to the MLST database (https://www.pubmlst.org). §Brand A is produced in Europe; Brand B is produced in the United Kingdom. ¶These 2 samples correspond to 2 different batches and were acquired at different times (October 2019 and January 2020). #QD resistance was tested only against E. faecium isolates. Successful transfer of ampicillin resistance is underlined (AMP) and all transconjugants exhibited high values of ampicillin resistance (16–256 mg/L).and.

Main Article

1These authors were co–principal investigators.

2These authors are active EFWISG members.

Page created: June 11, 2021
Page updated: July 19, 2021
Page reviewed: July 19, 2021
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external